| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders
|
García-Gutiérrez, María S.
|
|
|
213 |
C |
p.
|
artikel
|
| 2 |
An in vitro pharmacogenomic approach reveals subtype-specific therapeutic vulnerabilities in atypical teratoid/rhabdoid tumors (AT/RT)
|
Pauck, David
|
|
|
213 |
C |
p.
|
artikel
|
| 3 |
A panel of altered blood oxysterols in patients with mild cognitive impairment: A novel combined diagnostic marker
|
An, Yu
|
|
|
213 |
C |
p.
|
artikel
|
| 4 |
Butyrate-engineered yeast activates Nppa and Sgcg genes and reduces radiation-induced heart damage via the gut-heart axis
|
Wu, Jiahao
|
|
|
213 |
C |
p.
|
artikel
|
| 5 |
Cardioprotective effect of crocin in patients with breast cancer receiving anthracycline-based chemotherapy: A randomized, double-blind, placebo-controlled study
|
Li, Xinye
|
|
|
213 |
C |
p.
|
artikel
|
| 6 |
Correspondence: Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE-2 study
|
Hsu, Chang-Yuan
|
|
|
213 |
C |
p.
|
artikel
|
| 7 |
Corrigendum to “Ectopic expression of NKG7 enhances CAR-T function and improves the therapeutic efficacy in liquid and solid tumors” [Pharmacol. Res. 210 (2024) 107506]
|
Chen, Yuxin
|
|
|
213 |
C |
p.
|
artikel
|
| 8 |
Decoding TGR5: A comprehensive review of its impact on cerebral diseases
|
Zhang, Zehan
|
|
|
213 |
C |
p.
|
artikel
|
| 9 |
Development of chimeric Nanobody-Granzyme B functionalized ferritin nanoparticles for precise tumor therapy
|
Xia, Baijin
|
|
|
213 |
C |
p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
213 |
C |
p.
|
artikel
|
| 11 |
Effects of nanocurcumin supplementation on metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials
|
Wilar, Gofarana
|
|
|
213 |
C |
p.
|
artikel
|
| 12 |
Effects of natural products on macrophage immunometabolism: A new frontier in the treatment of metabolic diseases
|
Li, Jiani
|
|
|
213 |
C |
p.
|
artikel
|
| 13 |
From bench to bedside: Developing CRISPR/Cas-based therapy for ocular diseases
|
Zhao, Qing
|
|
|
213 |
C |
p.
|
artikel
|
| 14 |
Glutamine deprivation confers immunotherapy resistance by inhibiting IFN-γ signaling in cancer cells
|
Yuan, Zhiwei
|
|
|
213 |
C |
p.
|
artikel
|
| 15 |
Gut microbiome-derived indole-3-carboxaldehyde regulates stress vulnerability in chronic restraint stress by activating aryl hydrocarbon receptors
|
Chen, Congcong
|
|
|
213 |
C |
p.
|
artikel
|
| 16 |
Gut microbiota derived DCA enhances FOLFOX efficacy via Ugt1a6b mediated enterohepatic circulation in colon cancer
|
Fang, Qian
|
|
|
213 |
C |
p.
|
artikel
|
| 17 |
Histone lysine crotonylation accelerates ACSL4-mediated ferroptosis of keratinocytes via modulating autophagy in diabetic wound healing
|
Li, Fengjuan
|
|
|
213 |
C |
p.
|
artikel
|
| 18 |
HVEM as a tumor-intrinsic regulator in non-small cell lung cancer: Suppression of metastasis via glycolysis inhibition and modulation of macrophage polarization
|
Yao, Yuanshan
|
|
|
213 |
C |
p.
|
artikel
|
| 19 |
Hydrogels empowered mesenchymal stem cells and the derived exosomes for regenerative medicine in age-related musculoskeletal diseases
|
Liu, Lixin
|
|
|
213 |
C |
p.
|
artikel
|
| 20 |
Inhibition of Kv1.3 channel restrains macrophage M2 polarization and ameliorates renal fibrosis via regulating STAT6 phosphorylation
|
Chen, Yanshan
|
|
|
213 |
C |
p.
|
artikel
|
| 21 |
Interleukin-2 and its receptors: Implications and therapeutic prospects in immune-mediated disorders of central nervous system
|
Zhang, Yiwei
|
|
|
213 |
C |
p.
|
artikel
|
| 22 |
IUPHAR Review: Alpha6-containing GABAA receptors – Novel targets for the treatment of schizophrenia
|
Chiou, Lih-Chu
|
|
|
213 |
C |
p.
|
artikel
|
| 23 |
IUPHAR review: Drug repurposing in Schizophrenia – An updated review of clinical trials
|
Zaki, Jihan K.
|
|
|
213 |
C |
p.
|
artikel
|
| 24 |
IUPHAR review: Eating disorders, gut microbiota dysbiosis and epigenetic aberrations
|
Nohesara, Shabnam
|
|
|
213 |
C |
p.
|
artikel
|
| 25 |
Lactobacillus vaginalis alleviates DSS induced colitis by regulating the gut microbiota and increasing the production of 3-indoleacrylic acid
|
Wang, Zhuoya
|
|
|
213 |
C |
p.
|
artikel
|
| 26 |
Neuronal PCSK9 regulates cognitive performances via the modulation of ApoER2 synaptic localization
|
Pelucchi, Silvia
|
|
|
213 |
C |
p.
|
artikel
|
| 27 |
PEPITEM, its tripeptide pharmacophores and their peptidomimetic analogues regulate the inflammatory response through parenteral and topical dosing in models of peritonitis and psoriasis
|
Saviano, Anella
|
|
|
213 |
C |
p.
|
artikel
|
| 28 |
Pharmacological regression of atherosclerotic plaque in patients with type 2 diabetes
|
Bucciarelli, Loredana
|
|
|
213 |
C |
p.
|
artikel
|
| 29 |
Preclinical development of a standardized extract of Ilex paraguariensis A.St.-Hil for the treatment of obesity and metabolic syndrome
|
Tolouei, Sara E.L.
|
|
|
213 |
C |
p.
|
artikel
|
| 30 |
Protective effects and mechanisms of quercetin in animal models of hyperuricemia: A systematic review and meta-analysis
|
Bian, Xueren
|
|
|
213 |
C |
p.
|
artikel
|
| 31 |
Quality and composition control of complex TCM preparations through a novel “Herbs-in vivo Compounds-Targets-Pathways” network methodology: The case of Lianhuaqingwen capsules
|
Chen, Simian
|
|
|
213 |
C |
p.
|
artikel
|
| 32 |
Reply to the letter comment of Su Boon Yong MD, PhD and colleagues to: Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE− 2 study
|
Berra, Cesare
|
|
|
213 |
C |
p.
|
artikel
|
| 33 |
RNA aptamer-mediated RNA nanotechnology for potential treatment of cardiopulmonary diseases
|
Xia, Boyu
|
|
|
213 |
C |
p.
|
artikel
|
| 34 |
SIRT1: A likely key for future therapeutic strategies for pain management
|
Ilari, Sara
|
|
|
213 |
C |
p.
|
artikel
|
| 35 |
Systematic druggable genome-wide Mendelian randomization to identify therapeutic targets and dominant flora for ulcerative colitis
|
Ou, Haiya
|
|
|
213 |
C |
p.
|
artikel
|
| 36 |
Targeted gut microbiome therapy: Applications and prospects of probiotics, fecal microbiota transplantation and natural products in the management of type 2 diabetes
|
Qin, Luqi
|
|
|
213 |
C |
p.
|
artikel
|
| 37 |
Targeting TIPARP in ischemic stroke: A promising therapeutic strategy and future directions
|
Pan, Yinuo
|
|
|
213 |
C |
p.
|
artikel
|
| 38 |
The efficacy of sodium-glucose transporter 2 inhibitors in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
|
Li, Hongsheng
|
|
|
213 |
C |
p.
|
artikel
|
| 39 |
The essential role of sphingolipids in TRPC5 ion channel localization and functionality within lipid rafts
|
Wan, Junliang
|
|
|
213 |
C |
p.
|
artikel
|
| 40 |
The role of HIF-1α in hypoxic metabolic reprogramming in osteoarthritis
|
Zhang, Jie
|
|
|
213 |
C |
p.
|
artikel
|
| 41 |
Toward an immunology-based classification of pain disorders?
|
Rosenström, A.H.C.
|
|
|
213 |
C |
p.
|
artikel
|
| 42 |
TPC2 in drug development: Emerging target for cancer, viral infections, cardiovascular diseases, and neurological disorders
|
Alharbi, Abeer F.
|
|
|
213 |
C |
p.
|
artikel
|
Tijdschrift beschrijving